Imatinib mesylate is extremely active in Philadelphia-positive (Ph+) chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), but it’s effect on the outcome of a subsequent allogeneic stem cell transplantation (SCT) is still a matter of debate. We report our experience in ten cases of Ph+ leukaemias (4 ALL and 6 CML) who underwent SCT after Imatinib therapy and compared to 39 historical controls (30 CML and 9 ALL) transplanted without Imatinib pre-treatment. No difference was seem in terms of engraftment, time to recovery, incidence of acute and chronic graft-versus-host disease (GVHD) and infections.

Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias

TIRIBELLI, Mario;DAMIANI, Daniela;FANIN, Renato
2004-01-01

Abstract

Imatinib mesylate is extremely active in Philadelphia-positive (Ph+) chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), but it’s effect on the outcome of a subsequent allogeneic stem cell transplantation (SCT) is still a matter of debate. We report our experience in ten cases of Ph+ leukaemias (4 ALL and 6 CML) who underwent SCT after Imatinib therapy and compared to 39 historical controls (30 CML and 9 ALL) transplanted without Imatinib pre-treatment. No difference was seem in terms of engraftment, time to recovery, incidence of acute and chronic graft-versus-host disease (GVHD) and infections.
File in questo prodotto:
File Dimensione Formato  
16. bmt 2004.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: Non pubblico
Dimensione 73.17 kB
Formato Adobe PDF
73.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/878388
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact